Skip to main content
. 2019 Feb 1;26(1):e70–e80. doi: 10.3747/co.26.4220

TABLE I.

Administration of trastuzumab, by route and breast cancer (BCa) statusa

Dose Intravenous Subcutaneous


Early BCa Metastatic BCa 3-Weekly Early BCa 3-Weekly Metastatic BCa 3-Weekly

Weekly 3-Weekly
Loading 4 mg/kg over 90 min 8 mg/kg over 90 min 8 mg/kg over 90 min None None

Maintenance
 First 2 mg/kg over 90 min 6 mg/kg over 90 min 6 mg/kg over 90 min 600 mg over 2–5 min given in the thigh (alternating left and right)
 Subsequent 2 mg/kg over 30 min 6 mg/kg over 30 min 6 mg/kg over 30 min
a

Adapted from European Medicines Agency, 201010.